These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15584995)

  • 21. High dose factor VIIa improves clot structure and stability in a model of haemophilia B.
    Wolberg AS; Allen GA; Monroe DM; Hedner U; Roberts HR; Hoffman M
    Br J Haematol; 2005 Dec; 131(5):645-55. PubMed ID: 16351642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of recombinant factor VIIa during orthotopic liver transplantation.
    De Gasperi A; Baudo F
    Liver Transpl; 2006 Jul; 12(7):1176-7; author reply 1178-9. PubMed ID: 16799955
    [No Abstract]   [Full Text] [Related]  

  • 23. Novel point mutation in a leucine-rich repeat of the GPIbalpha chain of the platelet von Willebrand factor receptor, GPIb/IX/V, resulting in an inherited dominant form of Bernard-Soulier syndrome affecting two unrelated families: the N41H variant.
    Vettore S; Scandellari R; Moro S; Lombardi AM; Scapin M; Randi ML; Fabris F
    Haematologica; 2008 Nov; 93(11):1743-7. PubMed ID: 18815197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DDAVP in Bernard-Soulier syndrome.
    Mant MJ
    Thromb Res; 1988 Oct; 52(1):77-8. PubMed ID: 3201400
    [No Abstract]   [Full Text] [Related]  

  • 25. Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma.
    Szlam F; Taketomi T; Sheppard CA; Kempton CL; Levy JH; Tanaka KA
    Anesth Analg; 2008 Mar; 106(3):719-24, table of contents. PubMed ID: 18292408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use.
    Sobieszczyk S; Breborowicz GH; Platicanov V; Tanchev S; Kessler CM
    Acta Obstet Gynecol Scand; 2006; 85(10):1239-47. PubMed ID: 17068684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemobilia and Bernard-Soulier syndrome.
    Koyama T; Fujimoto K; Okamoto K; Iwakiri R; Inoue E; Shimamoto Y
    Am J Gastroenterol; 1996 Mar; 91(3):619-20. PubMed ID: 8633533
    [No Abstract]   [Full Text] [Related]  

  • 28. Course of pregnancy and birth in a patient with Bernard-Soulier syndrome--a case report.
    Rahimi G; Rellecke S; Mallmann P; Nawroth F
    J Perinat Med; 2005; 33(3):264-6. PubMed ID: 15914354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antihemorrhagic prophylaxis in low risk surgery in Bernard-Soulier syndrome].
    González González G; Rodríguez Agea E; Ruiz Zafra V
    Rev Esp Anestesiol Reanim; 2005 Nov; 52(9):576-7. PubMed ID: 16363308
    [No Abstract]   [Full Text] [Related]  

  • 30. Recombinant activated factor VII: current perspectives and Epworth experience.
    Labattaglia MP; Ihle B
    Heart Lung Circ; 2007; 16 Suppl 3():S96-101. PubMed ID: 17627885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intractable gastrointestinal bleeding from angiodysplasia in a patient of Bernard-Soulier syndrome--report of a case--.
    Okita R; Hihara J; Konishi K; Osaki A; Yoshida K; Yamaguchi Y; Toge T; Fujimura K; Iwata T; Sawamura A
    Hiroshima J Med Sci; 2005 Dec; 54(4):113-5. PubMed ID: 16398056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anesthetic and perioperative management of a patient with Bernard-Soulier syndrome.
    Kostopanagiotou G; Siafaka I; Sikiotis C; Smyrniotis V
    J Clin Anesth; 2004 Sep; 16(6):458-60. PubMed ID: 15567653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perioperative management of a patient with Bernard-Soulier syndrome for third molar surgery.
    Hartman MJ; Caccamese JF; Bergman SA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 May; 103(5):626-9. PubMed ID: 17174124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased thrombotic tendency in mouse models of the Bernard-Soulier syndrome.
    Strassel C; Nonne C; Eckly A; David T; Leon C; Freund M; Cazenave JP; Gachet C; Lanza F
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):241-7. PubMed ID: 17095718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular genetics and transfusion management in a child with Bernard Soulier syndrome.
    Bowers MJ; Orr NJ; Dempsey S; Alexander HD
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):409-11. PubMed ID: 16788318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study.
    Petersen LC; Nørby PL; Branner S; Sørensen BB; Elm T; Stennicke HR; Persson E; Bjørn SE
    Thromb Res; 2005; 116(1):75-85. PubMed ID: 15850611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical aspect of platelet adhesion disorders].
    Okamura T
    Fukuoka Igaku Zasshi; 2001 Apr; 92(4):80-8. PubMed ID: 11517897
    [No Abstract]   [Full Text] [Related]  

  • 38. Recombinant factor VIIa: safety and efficacy.
    Goodnough LT; Shander AS
    Curr Opin Hematol; 2007 Sep; 14(5):504-9. PubMed ID: 17934358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Perioperative use of recombinant activated factor VII (rF VIIa) in a patient with hemophilia A having inhibitors].
    Kawasaki Y; Saeki N; Kawamoto M; Yuge O; Fujii T
    Masui; 2005 Aug; 54(8):926-8. PubMed ID: 16104555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.